Top-Accessed Article: Skin Markers of Occult Spinal Dysraphism in Children

autoimmune target in alopecia areata. J Am Acad Dermatol. 2009;61(3):529530. 13. Nagai H, Oniki S, Oka M, Horikawa T, Nishigori C. Induction of cellular immunity against hair follicle melanocyte causes alopecia. Arch Dermatol Res. 2006; 298(3):131-134. 14. Au WY, Yeung CK, Chan HH, Lie AK. Generalized vitiligo after lymphocyte infusion for relapsed leukaemia. Br J Dermatol. 2001;145(6):1015-1017. 15. Nagler A, Goldenhersh MA, Levi-Schaffer F, Bystryn JC, Klaus SN. Total leucoderma: a rare manifestation of cutaneous chronic graft-versus-host disease. Br J Dermatol. 1996;134(4):780-783. 16. Sanli H, Akay BN, Arat M, et al. Vitiligo after hematopoietic cell transplantation: six cases and review of the literature. Dermatology. 2008;216(4):349-354. 17. Motl SE, Fausel C. Recurring chemotherapy-associated alopecia areata: case report and literature review. Pharmacotherapy. 2003;23(1):104-108. 18. Brazzelli V, Roveda E, Prestinari F, et al. Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a noninvasive colorimetric assessment. Pediatr Dermatol. 2006;23(2):175-178. 19. Mariani S, Abruzzese E, Basciani S, et al. Reversible hair depigmentation in a patient treated with imatinib [published online December 19, 2010]. Leuk Res. 2010;35(6):e64-e66. doi:10.1016/j.leukres.2010.11.028. 20. Raanani P, Goldman JM, Ben-Bassat I. Challenges in oncology: case 3: depigmentation in a chronic myeloid leukemia patient treated with STI-571. J Clin Oncol. 2002;20(3):869-870. 21. Routhouska S, Gilliam AC, Mirmirani P. Hair depigmentation during chemotherapy with a class III/V receptor tyrosine kinase inhibitor. Arch Dermatol. 2006; 142(11):1477-1479. 22. Huang CL, Kuo TT, Chan HL. Acquired generalized hypohidrosis/anhidrosis with subclinical Sjögren’s syndrome: report of a case with diffuse syringolymphoid hyperplasia and lymphocytic sialadenitis. J Am Acad Dermatol. 1996;35(2, pt 2):350-352. 23. Akosa AB, Lampert IA. The sweat gland in graft versus host disease. J Pathol. 1990;161(3):261-266. 24. Cheshire WP, Fealey RD. Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management. Drug Saf. 2008;31(2):109-126. 25. Häusermann P, Walter RB, Halter J, et al. Cutaneous graft-versus-host disease: a guide for the dermatologist. Dermatology. 2008;216(4):287-304.